Side by Side

Compare

Read two to four stocks on the same scale — return, valuation and volatility in one table.

SelectedToday5Y Return

ALMSAlumis Inc− 2.20%− 16.54%
Partial Period · Jun 24, 2024 — Aug 31, 2026
GTBPGT Biopharma Inc+ 2.34%− 99.90%
ANVSAnnovis Bio Inc+ 2.17%− 96.06%

Period Return

Each series is converted to a percentage of its own starting point, so all of them begin at zero. What is compared is the return over the period, not price levels.

ALMS− 16.5%GTBP− 99.9%ANVS− 96.1%Tap or hover the chart for values along the way

Metric	ALMSAlumis Inc	GTBPGT Biopharma Inc	ANVSAnnovis Bio Inc
Return
Last Price	11.11	0.26	1.41
Daily Change	− 2.20%	+ 2.34%	+ 2.17%
Period ReturnPast 5 Years	− 16.54%Jun 24, 2024 — Aug 31, 2026	− 99.90%	− 96.06%
Valuation
Market Cap	$1.42 B	$11.5 M	$48.9 M
P/E Ratio	—	2.13	—
Dividend Yield	—	—	—
Net MarginTrailing 12M	6,114.6%	26,209.5%	—
Risk
Beta	0.68	0.85	1.30
52-Week Range	3.76 — $31.35	0.25 — $1.37	1.32 — $5.50
Company
Sector	—	—	—
Industry	Pharmaceuticals	Biotechnology	Biotechnology

Company

ALMSPharmaceuticals
GTBPBiotechnology
ANVSBiotechnology

Alpaca · SIPUpdated 01:0615 Minutes Delayed

To Understand This

P/E and the Valuation RatiosYou can't tell whether a stock is cheap or expensive by looking at its price.Diversification: How Many Baskets Are Enough?Owning ten different stocks is not the same as owning ten different risks.